Innova Biosciences Limited has announced the launch of an application using its Lightning-Link™ technology to provide a further addition to its conjugation capabilities and product offering.
Lightning-Link technology is used to join biomolecules forming ‘conjugates’, which are widely employed in bioscience, medical research as well as in diagnostic applications.
Innova has expanded its capabilities in a new application area, using Lightning-Link to speed up conjugation of the fluorescent protein phycoerythrin (PE) to disease-sensing monoclonal antibodies.
Using a flow cytometer, a machine which is widely available in research and clinical laboratories worldwide, the resulting PE conjugates can be used to detect a variety of disease disorders. To address these needs Innova has launched its new Lightning-Link PE kit.
The Lightning-Link PE kit is a further addition to Innova's existing range of Lightning-Link conjugation kits, which include Lightning-Link HRP (Horse Radish Peroxidase) and Lightning-Link AP (Alkaline Phosphatase). These kits complement other Innova offerings which include a range of phosphate detection reagents, affinity resins and assay kits as well as Innova’s conjugation services. Innova has a pipeline of additional exciting conjugation products which will be launched throughout 2007.